26/07/2023 3:31:51 PM | Source: Reuters
Indian drugmaker Cipla posts 45% rise in Q1 profit on strong domestic business
Indian pharmaceutical major Cipla reported a 45% growth in first-quarter profit on Wednesday, helped by strength in its domestic drugs business and easing input costs.
Consolidated net profit for India's third-largest drugmaker by sales climbed to 9.96 billion rupees ($121.46 million) for the quarter ended June 30 from 6.86 billion rupees a year earlier.
Analysts, on average, expected a profit of 8.36 billion rupees.
Disclaimer:
The content of this article is for informational purposes only and should not be considered financial or investment advice. Investments in financial markets are subject to market risks, and past performance is not indicative of future results. Readers are strongly advised to consult a licensed financial expert or advisor for tailored advice before making any investment decisions. The data and information presented in this article may not be accurate, comprehensive, or up-to-date. Readers should not rely solely on the content of this article for any current or future financial references.
To Read Complete Disclaimer Click Here
Latest News
The Nifty shredded 320 points to settle at 23,025 - ...
Daily Technical Outlook By Axis Securities Ltd
Daily Derivatives Report By Axis Securities Ltd
Daemyung Sono Group moves to acquire T'way Air
Nifty Retreats from 23,400 Resistance, Tests 23,000 ...
World at a critical inflection point, 2025 a year of...
Avenue Supermarts gains on opening new store in Amri...
Nifty opened with an upward gap and traded with extr...
HCL Technologies gains on launching new center in Hy...
South Korean battery firms make record investments a...
